Lakewood, Colorado, US, February 14, 2023 – Terumo Blood and Cell Technologies announces US Food and Drug Administration (FDA) clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, ...
AUSTIN, Texas, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Secure Transfusion Solutions (STS), a private life sciences company pioneering innovative solutions to overcome the nation’s growing blood and platelet ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced ...
Netherlands: A multicenter study has described the development of a dynamic prediction tool that helps tailor platelet ...
Bleeding is a frequent complication after BMT, associated with morbidity and mortality. The relationship between hemorrhage and low platelet count was first shown in 1962 by Gaydos et al1 in leukemic ...
Terumo Blood and Cell Technologies has announced US Food and Drug Administration (FDA) clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, which supports extended shelf life of ...
LAKEWOOD, Colo., Feb. 16, 2023 /PRNewswire/ -- Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD ® WB Platelet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback